Evidence map›Paper›PMID 25275136›Full record

ArticleJournal of virology2014

Viral reprogramming of the Daxx histone H3.3 chaperone during early Epstein-Barr virus infection.

Kevin Tsai, Lilian Chan, Rebecca Gibeault, Kristen Conn, Jayaraju Dheekollu, John Domsic, Ronen Marmorstein, Luis M Schang, Paul M Lieberman

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Physiology and molecular biology of plants : an international journal of functional plant biology · 2025
    Article
  4. Chromatin Control of EBV Infection and Latency.Current topics in microbiology and immunology · 2025
    Article
  5. Review
  6. Sp140L functions as a herpesvirus restriction factor suppressing viral transcription and activating interferon-stimulated genes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Epigenetic control of the Epstein-Barr lifecycle.Current opinion in virology · 2022
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Kevin TsaiThe Wistar Institute, Philadelphia, Pennsylvania, USA Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lilian ChanThe Wistar Institute, Philadelphia, Pennsylvania, USA.
Rebecca GibeaultDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
Kristen ConnDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
Jayaraju DheekolluThe Wistar Institute, Philadelphia, Pennsylvania, USA.
John DomsicThe Wistar Institute, Philadelphia, Pennsylvania, USA Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ronen MarmorsteinThe Wistar Institute, Philadelphia, Pennsylvania, USA Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Luis M SchangDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
Paul M LiebermanThe Wistar Institute, Philadelphia, Pennsylvania, USA lieberman@wistar.org.
The Wistar Institute · USUniversity of Alberta · CAUniversity of Pennsylvania · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHELLEY L BERGER · 1985 to 2026
$222.3M
Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
STRUCTURAL BASIS FOR EPIGENETICS IN AGING AND LONGEVITYP01AG031862 · NIA · WISTAR INSTITUTE · PI GARCIA, BENJAMIN A · 2008 to 2022
$28.3M
TRAINING PROGRAM IN BASIC CANCER RESEARCHT32CA009171 · NCI · WISTAR INSTITUTE · PI Alessandro Gardini · 1985 to 2026
$15.3M
Role of LANA-RBP-jk During Early KSHV InfectionP01CA174439 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2013 to 2018
$8.7M
Regulation of Epstein-Barr Virus LatencyR01CA093606 · NCI · WISTAR INSTITUTE · PI LIEBERMAN, PAUL M. · 2002 to 2022
$6.7M
Epigenetic Regulation of Epstein-Barr Virus Latency ProgramsR01DE017336 · NIDCR · WISTAR INSTITUTE · PI PAUL M. LIEBERMAN · 2005 to 2026
$6.5M
CIHR MOP106452NCI NIH HHS CA 093606NCI NIH HHS P01 CA174439NCI NIH HHS P30 CA010815NCI NIH HHS P30 CA016520NCI NIH HHS R01 CA093606NCI NIH HHS T32 CA009171NIA NIH HHS AG031862NIA NIH HHS P01 AG031862NIDCR NIH HHS DE 017336NIDCR NIH HHS R01 DE017336Wellcome Trust
6 · The paper itself

Abstract

unlabelledHost chromatin assembly can function as a barrier to viral infection. Epstein-Barr virus (EBV) establishes latent infection as chromatin-assembled episomes in which all but a few viral genes are transcriptionally silent. The factors that control chromatin assembly and guide transcription regulation during the establishment of latency are not well understood. Here, we demonstrate that the EBV tegument protein BNRF1 binds the histone H3.3 chaperone Daxx to modulate histone mobility and chromatin assembly on the EBV genome during the early stages of primary infection. We demonstrate that BNRF1 substitutes for the repressive cochaperone ATRX to form a ternary complex of BNRF1-Daxx-H3.3-H4, using coimmunoprecipitation and size-exclusion chromatography with highly purified components. FRAP (fluorescence recovery after photobleaching) assays were used to demonstrate that BNRF1 promotes global mobilization of cellular histone H3.3. Mutation of putative nucleotide binding motifs on BNRF1 attenuates the displacement of ATRX from Daxx. We also show by immunofluorescence combined with fluorescence in situ hybridization that BNRF1 is important for the dissociation of ATRX and Daxx from nuclear bodies during de novo infection of primary B lymphocytes. Virion-delivered BNRF1 suppresses Daxx-ATRX-mediated H3.3 loading on viral chromatin as measured by chromatin immunoprecipitation assays and enhances viral gene expression during early infection. We propose that EBV tegument protein BNRF1 replaces ATRX to reprogram Daxx-mediated H3.3 loading, in turn generating chromatin suitable for latent gene expression. IMPORTANCE: Epstein-Barr Virus (EBV) is a human herpesvirus that efficiently establishes latent infection in primary B lymphocytes. Cellular chromatin assembly plays an important role in regulating the establishment of EBV latency. We show that the EBV tegument protein BNRF1 functions to regulate chromatin assembly on the viral genome during early infection. BNRF1 alters the host cellular chromatin assembly to prevent antiviral repressive chromatin and establish chromatin structure permissive for viral gene expression and the establishment of latent infection.

Indexed as

Host-Pathogen InteractionsVirus LatencyAdaptor Proteins, Signal TransducingBinding SitesB-LymphocytesCells, CulturedChromatography, GelCo-Repressor ProteinsDNA HelicasesFluorescence Recovery After PhotobleachingFluorescent Antibody TechniqueHerpesvirus 4, HumanHumansImmunoprecipitationIn Situ Hybridization, FluorescenceMolecular ChaperonesAdaptor Proteins, Signal TransducingATRX protein, humanCo-Repressor ProteinsDAXX protein, humanDNA HelicasesMolecular ChaperonesMutant ProteinsNuclear ProteinsP140 protein, Epstein-barr virusViral Envelope ProteinsX-linked Nuclear Protein

Identifiers

PMID25275136
PMCPMC4249116
OpenAlexW2171967738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.